期刊文献+

血清8-羟基脱氧鸟嘌呤水平与Graves眼病关系的临床研究 被引量:4

The association between 8-hydroxy-deoxyguanosine and Graves' ophthalmopathy
原文传递
导出
摘要 探讨血清8-羟基脱氧鸟嘌呤(8-hydroxy-deoxyguanosine,8-OHdG)水平在Graves眼病发病机制中的作用及与Graves眼病活动性的关系。用酶联免疫吸附法(ELISA)检测48例Graves眼病患者(GO组)和30例单纯Graves病而无眼征的患者(GD组)的血清8-OHdG水平,同时检测30名健康体检者作为对照组。与对照组相比,GO组和GD组的血清8-OHdG水平明显增高[(2.98 ± 1.33),(2.07 ± 1.30)对(0.72 ± 0.93)ng/ml, P〈0.05];且GO组的血清8-OHdG水平明显高于GD组(P〈0.05);Pearson相关性分析显示血清8-OHdG水平与临床疾病活动分数呈显著正相关(r=0.54,P〈0.01)。Graves眼病患者外周血8-OHdG水平明显增高,提示氧化应激与Graves眼病的发病机制有关,血清8-OHdG水平可作为评价Graves眼病疾病活动度的良好指标。 To investigate the role played by 8-hydroxy-deoxyguanosine(8-OHdG) in patients with Graves′ ophthalmopathy(GO), and the association between 8-OHdG and the disease activity of GO. Serum levels of 8-OHdG were tested in 48 cases with GO and 30 cases with Graves′ disease(GD) without ophthalmopathy. 30 healthy subjects participated in this study as controls. 8-OHdG was detected by enzyme-linked immunosorbent assay(ELISA). Compared with the controls, the mean level of 8-OHdG in GO patients and GD patients was increased significantly[(2.98 ± 1.33),(2.07 ± 1.30) vs(0.72 ± 0.93)ng/ml, P〈0.05]. Mean 8-OHdG level in GO patients was markedly higher when compared to GD patients(P〈0.05). Pearson regression analysis showed that elevated levels of 8-OHdG were significantly correlated with the Clinical Activity Score of GO(r=0.54,P〈0.01). The serum level of 8-OHdG in GO patients was raised obviously, it implies that oxidative stress plays an important role in the pathogenesis of GO, and the serum level of 8-OHdG might act as an activity index of GO.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第4期322-323,共2页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目(81070626)
关键词 氧化应激 血清8-羟基脱氧鸟嘌呤水平 格雷夫斯眼病 Oxidative stress Serum levels of 8-hydroxy-deoxyguanosine Graves' ophthalmopathy
  • 相关文献

参考文献9

  • 1Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev, 2003,24:802-835. 被引量:1
  • 2Kaur A, Pandey S, Kumar S, et al. Oxidative stress profile in Graves' ophthalmopathy in indian patients. Orbit, 2010,29:97-101. 被引量:1
  • 3王坚,王扬天,邵加庆,赵明,王晓,杜宏.霉酚酸酯治疗甲状腺相关性眼病临床对照研究[J].医学研究生学报,2003,16(12):911-913. 被引量:7
  • 4Akarsu E, Buyukhatipoglu H, Aktaran S, et al. Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy. Clin Endocrinol, 2011,74 : 118-124. 被引量:1
  • 5Tope AM, Panemangalore M. Assessment of oxidative stress due to exposure to pesticides in plasma and urine of traditional limited-resource farm workers: formation of the DNA-adduct 8-hydroxy-2-deoxy- guanosine( 8-OHdG). J Environ Sci Health B, 2007,42 : 151-155. 被引量:1
  • 6Bednarek J, Wysocki H, Sowinski J. Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy. Clin Biochem, 2005,38 : 13-18. 被引量:1
  • 7Bartalena L, Tanda ML, Piantanida E, et al. Oxidative stress and Graves' ophthalmopathy : in vitro studies and therapeutic implications. Biofactors, 2003,9 : 155-163. 被引量:1
  • 8Tsai CC, Cheng CY, Liu CY, et al. Oxidative stress in patients with Graves' ophthalmopathy: relationship between oxidative DNA damage and clinical evolution. Eye, 2009,23 : 1725-1730. 被引量:1
  • 9Tsai CC, Wu SB, ChengCY, et ai. Increased oxidative DNA damage, lipid peroxidation, and reactive oxygen species in cultured orbital fibroblasts from patients with Graves' ophthalmopathy: evidence that oxidative stress has a role in this disorder. Eye, 2010,24 : 1520-1525. 被引量:1

二级参考文献11

  • 1Wiersinga WM, Prummel MF. An evidence-based approach to the treatment of Graves' ophthalmopathy[J]. Edocrinol Metab Clin N Am, 2000, 29(2):297-319. 被引量:1
  • 2Wiersinga WM, Prummel MF. Graves' ophthalmopathy: a rational approach to treatment[J]. Trends Endocrinol Metab, 2002, 13(7): 280-287. 被引量:1
  • 3Kahaly GJ, Rosler HP, Pitz S et al. Low- versus high-dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial[J]. J Clin Endocrinol Metab, 2000, 85(1): 102-108. 被引量:1
  • 4Inoue Y,Tsuboi T,Kouzaki A et al. Ophthalmic surgery in dysthyroid ophthalmopathy[J]. Thyroid, 2002, 12(3): 257-263. 被引量:1
  • 5Kauppinen-Makelin R, Karma A, Leinonen E et al. High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy[J]. Acta Ophthalmol Scand, 2002, 80(3): 316-321. 被引量:1
  • 6Prummel MF, Mourits M, Berghout A et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy[J]. N Engl J Med, 1989, 321:1353-1359. 被引量:1
  • 7Uysal AR, Corapcioglu D, Tonyukuk VC et al. Effect of octreotide treatment on Graves' ophthalmopathy[J]. Endocr J, 1999, 46(4): 573-577. 被引量:1
  • 8Kahaly G, Pitz S, Muller-Forell W et al. Randomized trial of intravenous immunoglobulins versus prednisolone in Graves' ophthalmopathy[J]. Clin Exp Immunol, 1996, 106(2): 197-202. 被引量:1
  • 9Balazs C, Kiss E, Vamos A et al. Immunomodulatory effect of pentoxifylline in Graves' ophthalmopathy(abstract)[J]. Orv Hetil, 1997, 138(1): 2869-2874. 被引量:1
  • 10Given-Wilson R,Pope RM,Michell MJ et al. The use of real-time orbital ultrasound in Graves' ophthalmopathy: A comparison with computed tomography[J]. Bj J Radiol, 1989, 62(6): 705-709. 被引量:1

共引文献6

同被引文献59

  • 1何剑峰,吴中耀,杨华胜,颜建华,毛羽翔,陈智聪,艾思明.甲状腺相关眼病339例临床分析[J].中华眼科杂志,2004,40(6):368-372. 被引量:20
  • 2Kazim M, Goldberg RA, Smith TJ. Insights into the pathogenesis of thyroid associated orbitopathy: evolving rationale for therapy[J]. Arch Ophthalmol, 2002,120:380-386. 被引量:1
  • 3Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves′ disease and ophthalmopathy[J]. Endocr Rev, 2003,24:802-835. 被引量:1
  • 4Ademoglu E, Ozbey N, Erbil Y. Determination of oxidative stress in thyroid tissue and plasma of patients with Graves′ disease[J]. Eur J Intern Med, 2006,7:545-550. 被引量:1
  • 5Bednarek J, Wysocki H, Sowinski J. Oxidative stress peripheral parameters in Graves′ disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy[J]. Clin Biochem, 2005,38:13-18. 被引量:1
  • 6Mano T, Sinohara R, Sawai Y, et al. Effects of thyroid hormone on coenzyme Q and other free radical scavengers in rat heart muscle[J]. J Endocrinol, 1995,145:131-136. 被引量:1
  • 7Asayama K, Kato K. Oxidative muscular injury and its relevance to hyperthyroidism[J]. Free Radic Biol Med, 1990,8:293-303. 被引量:1
  • 8Videla LA, Sir T, Wolff C. Increased lipid peroxidation in hyperthyroid patients: suppression by propylthiouracil treatment[J]. Free Radic Res Commun, 1988,5:1-10. 被引量:1
  • 9Venditti P, Balestrini M, Di Meo S, et al. Effect of thyroid state on lipid peroxidation,antioxidant defenses, and susceptibility to oxidative stress in rat tissues[J]. J Endocrinol, 1997,155:151-157. 被引量:1
  • 10Abalovich M, Llesuy S, Gutierrez S, et al. Peripheral parameters of oxidative stress in Graves′ disease: the effects of methimazole and 131 iodine treatments[J]. Clin Endocrinol (Oxf), 2003,59:321-327. 被引量:1

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部